• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Precision medicine in adult and pediatric obesity: a clinical perspective.成人与儿童肥胖症的精准医学:临床视角
Ther Adv Endocrinol Metab. 2019 Jul 27;10:2042018819863022. doi: 10.1177/2042018819863022. eCollection 2019.
2
Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment.成人 I 级肥胖伴难以控制 2 型糖尿病患者的减重手术:一项卫生技术评估。
Ont Health Technol Assess Ser. 2023 Dec 5;23(8):1-151. eCollection 2023.
3
Towards precision medicine in bariatric surgery prescription.迈向肥胖症手术处方的精准医学。
Rev Endocr Metab Disord. 2023 Oct;24(5):961-977. doi: 10.1007/s11154-023-09801-9. Epub 2023 May 2.
4
Bariatric surgery: an evidence-based analysis.减重手术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1.
5
Treatment Options for Severe Obesity in the Pediatric Population: Current Limitations and Future Opportunities.儿科重度肥胖症的治疗选择:当前的局限性和未来的机遇。
Obesity (Silver Spring). 2018 Jun;26(6):951-960. doi: 10.1002/oby.22196. Epub 2018 May 7.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
8
Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.儿童肥胖——评估、治疗与预防:内分泌学会临床实践指南
J Clin Endocrinol Metab. 2017 Mar 1;102(3):709-757. doi: 10.1210/jc.2016-2573.
9
Working toward precision medicine approaches to treat severe obesity in adolescents: report of an NIH workshop.努力实现精准医学方法以治疗青少年重度肥胖:NIH 研讨会报告。
Int J Obes (Lond). 2018 Nov;42(11):1834-1844. doi: 10.1038/s41366-018-0231-x. Epub 2018 Oct 3.
10
Contemporary medical, device, and surgical therapies for obesity in adults.成人肥胖的当代医学、器械及手术治疗方法。
Lancet. 2023 Apr 1;401(10382):1116-1130. doi: 10.1016/S0140-6736(22)02403-5. Epub 2023 Feb 9.

引用本文的文献

1
Incretin-based therapies for the treatment of obesity-related diseases.用于治疗肥胖相关疾病的基于肠促胰岛素的疗法。
NPJ Metab Health Dis. 2024 Nov 6;2(1):31. doi: 10.1038/s44324-024-00030-5.
2
Individual participant data meta-analysis of eating behaviour traits as effect modifiers in acceptance and commitment therapy-based weight management interventions.将饮食行为特征作为基于接受与承诺疗法的体重管理干预中效应修饰因素的个体参与者数据荟萃分析。
Int J Obes (Lond). 2025 Apr 10. doi: 10.1038/s41366-025-01759-9.
3
Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment.司美格鲁肽作为一种胰高血糖素样肽-1(GLP-1)激动剂:肥胖治疗的一项突破。
Pharmaceuticals (Basel). 2025 Mar 12;18(3):399. doi: 10.3390/ph18030399.
4
Exploring the Effect of an Obesity-Prevention Intervention on Various Child Subgroups: A Post Hoc Subgroup Analysis of the Kiel Obesity Prevention Study.探讨肥胖预防干预对不同儿童亚组的影响:基尔肥胖预防研究的事后亚组分析。
Nutrients. 2024 Sep 23;16(18):3220. doi: 10.3390/nu16183220.
5
Improving Health Behaviors and Weight Parameters With Motivational Interviewing and the TEEEN Program in an Ethnically and Socioeconomically Diverse Pediatric Population.通过动机性访谈和TEEEN项目改善不同种族和社会经济背景的儿科人群的健康行为和体重参数。
Am J Med Open. 2023 Apr 24;10:100042. doi: 10.1016/j.ajmo.2023.100042. eCollection 2023 Dec.
6
Semaglutide for weight loss: unanswered questions.司美格鲁肽用于减肥:未解决的问题。
Front Endocrinol (Lausanne). 2024 Jun 5;15:1382814. doi: 10.3389/fendo.2024.1382814. eCollection 2024.
7
Effectiveness and predictors of weight loss response to phentermine plus lifestyle modifications among youth in a paediatric weight management clinical setting.在儿科体重管理临床环境中,苯丁胺联合生活方式改变对青少年体重减轻反应的效果和预测因素。
Pediatr Obes. 2024 Aug;19(8):e13143. doi: 10.1111/ijpo.13143. Epub 2024 Jun 17.
8
A Real-World Study of the Effectiveness and Safety of Semaglutide for Weight Loss.司美格鲁肽用于减肥的有效性和安全性的真实世界研究。
Cureus. 2024 May 2;16(5):e59558. doi: 10.7759/cureus.59558. eCollection 2024 May.
9
Clinical effectiveness and predictors of response to topiramate plus lifestyle modification in youth with obesity seen in a weight management clinical setting.在体重管理临床环境中观察到的肥胖青少年中,托吡酯联合生活方式改变的临床疗效和反应预测因素。
Front Endocrinol (Lausanne). 2024 May 10;15:1369270. doi: 10.3389/fendo.2024.1369270. eCollection 2024.
10
An interpretable predictive deep learning platform for pediatric metabolic diseases.一个可解释的预测性深度学习平台,用于儿科代谢疾病。
J Am Med Inform Assoc. 2024 May 20;31(6):1227-1238. doi: 10.1093/jamia/ocae049.

本文引用的文献

1
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease.肥胖症、代谢综合征、2 型糖尿病和非酒精性脂肪性肝病发病机制中的表观遗传标记物和微生物群/代谢物诱导的表观遗传修饰。
Curr Diab Rep. 2019 May 1;19(6):31. doi: 10.1007/s11892-019-1151-4.
2
Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.二甲双胍或生活方式干预在糖尿病预防计划结果研究中的长期体重减轻效果。
Ann Intern Med. 2019 May 21;170(10):682-690. doi: 10.7326/M18-1605. Epub 2019 Apr 23.
3
Mobile Health Applications in Weight Management: A Systematic Literature Review.移动健康应用程序在体重管理中的应用:系统文献回顾。
Am J Prev Med. 2019 Jun;56(6):894-903. doi: 10.1016/j.amepre.2018.12.005. Epub 2019 Apr 17.
4
A systematic review of tailored eHealth interventions for weight loss.一项针对量身定制的电子健康减肥干预措施的系统评价。
Digit Health. 2019 Feb 5;5:2055207619826685. doi: 10.1177/2055207619826685. eCollection 2019 Jan-Dec.
5
Long and Short of It: Early Response Predicts Longer-Term Outcomes in Pediatric Weight Management.长短有别:早期反应可预测儿科体重管理的长期结果。
Obesity (Silver Spring). 2019 Feb;27(2):272-279. doi: 10.1002/oby.22367.
6
Heterogeneity in Response to Treatment of Adolescents with Severe Obesity: The Need for Precision Obesity Medicine.青少年重度肥胖治疗反应的异质性:精准肥胖医学的需求。
Obesity (Silver Spring). 2019 Feb;27(2):288-294. doi: 10.1002/oby.22369.
7
Obesity as a Disease: The Obesity Society 2018 Position Statement.肥胖是一种疾病:肥胖学会 2018 立场声明。
Obesity (Silver Spring). 2019 Jan;27(1):7-9. doi: 10.1002/oby.22378.
8
Personalized nutrition: pretreatment glucose metabolism determines individual long-term weight loss responsiveness in individuals with obesity on low-carbohydrate versus low-fat diet.个性化营养:在低碳水化合物与低脂肪饮食中,肥胖个体的预处理葡萄糖代谢决定了其个体长期减肥反应性。
Int J Obes (Lond). 2019 Oct;43(10):2037-2044. doi: 10.1038/s41366-018-0298-4. Epub 2018 Dec 19.
9
Eating Behaviour Predicts Weight Loss Six Months after Bariatric Surgery: A Longitudinal Study.进食行为预测减重手术后 6 个月的体重减轻:一项纵向研究。
Nutrients. 2018 Nov 2;10(11):1616. doi: 10.3390/nu10111616.
10
New Insights Regarding Genetic Aspects of Childhood Obesity: A Minireview.儿童肥胖症遗传因素的新见解:一篇综述。
Front Pediatr. 2018 Oct 4;6:271. doi: 10.3389/fped.2018.00271. eCollection 2018.

成人与儿童肥胖症的精准医学:临床视角

Precision medicine in adult and pediatric obesity: a clinical perspective.

作者信息

Bomberg Eric M, Ryder Justin R, Brundage Richard C, Straka Robert J, Fox Claudia K, Gross Amy C, Oberle Megan M, Bramante Carolyn T, Sibley Shalamar D, Kelly Aaron S

机构信息

Department of Pediatrics and Center for Pediatric Obesity Medicine, University of Minnesota, Minneapolis, 717 Delaware Street SE, Room 371, Minneapolis, MN 55414, USA.

Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.

出版信息

Ther Adv Endocrinol Metab. 2019 Jul 27;10:2042018819863022. doi: 10.1177/2042018819863022. eCollection 2019.

DOI:10.1177/2042018819863022
PMID:31384417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6661805/
Abstract

It remains largely unknown as to why some individuals experience substantial weight loss with obesity interventions, while others receiving these same interventions do not. Person-specific characteristics likely play a significant role in this heterogeneity in treatment response. The practice of precision medicine accounts for an individual's genes, environment, and lifestyle when deciding upon treatment type and intensity in order to optimize benefit and minimize risk. In this review, we first discuss biopsychosocial determinants of obesity, as understanding the complexity of this disease is necessary for appreciating how difficult it is to develop individualized treatment plans. Next, we present literature on person-specific characteristics associated with, and predictive of, weight loss response to various obesity treatments including lifestyle modification, pharmacotherapy, metabolic and bariatric surgery, and medical devices. Finally, we discuss important gaps in our understanding of the causes of obesity in relation to the suboptimal treatment outcomes in certain patients, and offer solutions that may lead to the development of more effective and targeted obesity therapies.

摘要

为何有些人在肥胖干预措施下体重显著减轻,而接受相同干预的其他人却没有,这在很大程度上仍然未知。个体特异性特征可能在这种治疗反应的异质性中发挥重要作用。精准医学的实践在决定治疗类型和强度时会考虑个体的基因、环境和生活方式,以优化益处并将风险降至最低。在本综述中,我们首先讨论肥胖的生物心理社会决定因素,因为了解这种疾病的复杂性对于认识制定个性化治疗方案有多困难是必要的。接下来,我们展示关于与各种肥胖治疗(包括生活方式改变、药物治疗、代谢和减肥手术以及医疗设备)的体重减轻反应相关并可预测该反应的个体特异性特征的文献。最后,我们讨论在理解肥胖原因与某些患者治疗效果欠佳之间的重要差距,并提供可能导致开发更有效和针对性更强的肥胖治疗方法的解决方案。